Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqi Fumai injection for septic shock and cardiogenic shock
ChiCTR1900026424Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Oct 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of yiqi fumai in septic shock and cardiogenic shock (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Hemodynamic monitoring and Lactate clearance rate. Started Oct 2019; status: recruiting.
02
Drugs
yiqi fumai
03
Conditions
septic shockcardiogenic shock
Beyond the preview
Go deeper on ChiCTR1900026424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026424.